IMVT icon

Immunovant

120 hedge funds and large institutions have $653M invested in Immunovant in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 50 increasing their positions, 30 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

48% less first-time investments, than exits

New positions opened: 29 | Existing positions closed: 56

65% less capital invested

Capital invested by funds: $1.86B → $653M (-$1.21B)

75% less funds holding in top 10

Funds holding in top 10: 41 (-3)

Holders
120
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$15.4M
Puts
$6.89M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$6.05M
27
$5.87M
28
$5.41M
29
$5.32M
30
$4.92M
31
$4.17M
32
$4.01M
33
$4M
34
$3.89M
35
$3.69M
36
$3.68M
37
$3.15M
38
$3.15M
39
$3.01M
40
$2.84M
41
$2.57M
42
$2.54M
43
$2.39M
44
$2.13M
45
$1.99M
46
$1.6M
47
$1.45M
48
$1.33M
49
$1.24M
50
$1.24M